Larvae (maggot) therapy - Wound debridement
You are here : Home > Formulary Search > Larvae (maggot) therapy - Wound debridement
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
R
Restrictions / Comments :
Important
On recommendation of TVN only
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Larvae (maggot) therapy
Indication :
Wound debridement
Group Name :
Keywords :
biobags, Debridement of chronic and hard to heal wounds, including venous and arterial ulcers, desloughing agents, larval therapy, maggot therapy, sterile larvae, lucilia sericata
Brand Names Include :
LarvE
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.
Other Indications
Below are listed other indications that Larvae (maggot) therapy is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Wound debridement.
- No records returned.